Proshares Nanotechnology Etf Performance
| TINY Etf | USD 47.65 0.82 1.75% |
The etf holds a Beta of 0.41, which implies possible diversification benefits within a given portfolio. As returns on the market increase, ProShares Nanotechnology's returns are expected to increase less than the market. However, during the bear market, the loss of holding ProShares Nanotechnology is expected to be smaller as well.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in ProShares Nanotechnology ETF are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, ProShares Nanotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
1 | Acquisition by Rendino Kevin of 18098 shares of ProShares Nanotechnology at 1.7396 subject to Rule 16b-3 | 11/01/2024 |
2 | London-based Briefcase raises 2.8 million to develop AI-powered accounting automation | 12/04/2024 |
3 | Capital Group launches its first small and mid-cap ETF in US market - ZAWYA | 01/16/2025 |
| In Threey Sharp Ratio | 0.06 |
ProShares |
ProShares Nanotechnology Relative Risk vs. Return Landscape
If you would invest 4,675 in ProShares Nanotechnology ETF on October 23, 2024 and sell it today you would earn a total of 90.00 from holding ProShares Nanotechnology ETF or generate 1.93% return on investment over 90 days. ProShares Nanotechnology ETF is currently generating 0.0429% in daily expected returns and assumes 1.5019% risk (volatility on return distribution) over the 90 days horizon. In different words, 13% of etfs are less volatile than ProShares, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ProShares Nanotechnology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ProShares Nanotechnology's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as ProShares Nanotechnology ETF, and traders can use it to determine the average amount a ProShares Nanotechnology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0286
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | TINY |
Estimated Market Risk
| 1.5 actual daily | 13 87% of assets are more volatile |
Expected Return
| 0.04 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average ProShares Nanotechnology is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ProShares Nanotechnology by adding it to a well-diversified portfolio.
ProShares Nanotechnology Fundamentals Growth
ProShares Etf prices reflect investors' perceptions of the future prospects and financial health of ProShares Nanotechnology, and ProShares Nanotechnology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ProShares Etf performance.
| Return On Asset | -0.03 | |||
| Profit Margin | (22.08) % | |||
| Operating Margin | (263.42) % | |||
| Current Valuation | 51.56 M | |||
| Shares Outstanding | 31.17 M | |||
| Price To Earning | (2.45) X | |||
| Price To Book | 0.50 X | |||
| Price To Sales | 22.42 X | |||
| Revenue | 917 K | |||
| Cash And Equivalents | 17.92 M | |||
| Cash Per Share | 0.43 X | |||
| Total Debt | 5 M | |||
| Debt To Equity | 0.07 % | |||
| Cash Flow From Operations | (6.53 M) | |||
| Earnings Per Share | (0.53) X | |||
| Total Asset | 1.92 M | |||
| Retained Earnings | (123.29 M) | |||
| Current Asset | 18.88 M | |||
| Current Liabilities | 2.47 M | |||
About ProShares Nanotechnology Performance
Evaluating ProShares Nanotechnology's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if ProShares Nanotechnology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if ProShares Nanotechnology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
The index consists of companies focused on making or applying nanotechnology innovations that allow for improved products, processes, or techniques through control or measurement of material at nanoscale. Proshares Nanotechnology is traded on NYSEARCA Exchange in the United States.| ProShares Nanotechnology has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 917 K. Net Loss for the year was (20.25 M) with profit before overhead, payroll, taxes, and interest of 917 K. | |
| ProShares Nanotechnology ETF currently holds about 17.92 M in cash with (6.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.43. | |
| Latest headline from news.google.com: Capital Group launches its first small and mid-cap ETF in US market - ZAWYA | |
| The fund maintains 99.7% of its assets in stocks |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in ProShares Nanotechnology ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
The market value of ProShares Nanotechnology is measured differently than its book value, which is the value of ProShares that is recorded on the company's balance sheet. Investors also form their own opinion of ProShares Nanotechnology's value that differs from its market value or its book value, called intrinsic value, which is ProShares Nanotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ProShares Nanotechnology's market value can be influenced by many factors that don't directly affect ProShares Nanotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ProShares Nanotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if ProShares Nanotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ProShares Nanotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.